Related references
Note: Only part of the references are listed.A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease
Everett H. Meyer et al.
BLOOD (2013)
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
Nicola Gagliani et al.
NATURE MEDICINE (2013)
Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants
J. D. Scandling et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies
Giuseppe Messina et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
Aristeidis Chaidos et al.
BLOOD (2012)
Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion
Yong Chan Kim et al.
BLOOD (2012)
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa- generated induced Foxp3+ T reg cells
Jonathan M. Weiss et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo
Mahesh Yadav et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+ Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without Abrogating the Graft-versus-Leukemia Effect in Murine Models
Omar Duramad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
Ho-Jin Shin et al.
BLOOD (2011)
Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly
Anandharaman Veerapathran et al.
BLOOD (2011)
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism
Dennis B. Leveson-Gower et al.
BLOOD (2011)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
Induced Immune Tolerance for Kidney Transplantation
John D. Scandling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity
Keli L. Hippen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Type 1 regulatory T cells (Tr1) in autoimmunity
Caroline Pot et al.
SEMINARS IN IMMUNOLOGY (2011)
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway
Silvia Gregori et al.
BLOOD (2010)
Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
Katjana Klages et al.
CANCER RESEARCH (2010)
A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice
Noelia Casares et al.
JOURNAL OF IMMUNOLOGY (2010)
Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells
Julia K. Polansky et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease
Asha B. Pillai et al.
BLOOD (2009)
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
Holbrook E. Kohrt et al.
BLOOD (2009)
Epigenetic mechanisms of regulation of Foxp3 expression
Girdhari Lal et al.
BLOOD (2009)
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells
Piotr Trzonkowski et al.
CLINICAL IMMUNOLOGY (2009)
Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
Girdhari Lal et al.
JOURNAL OF IMMUNOLOGY (2009)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Reaulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces
Yuri P. Rubtsov et al.
IMMUNITY (2008)
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β-dependent manner
John Andersson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation
John D. Scandling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Differential impact of mammalian target of rapamycin inhibition on CD4(+)CD25(+)Foxp3(+) regulatory T cells compared with conventional CD4(+) T cells
Robert Zeiser et al.
BLOOD (2008)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Donor bone marrow type II (Non-Vα14Jα18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-γ and IL-4
Ji Hyung Kim et al.
JOURNAL OF IMMUNOLOGY (2007)
Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature
Jonathan A. Hill et al.
IMMUNITY (2007)
Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype
Dat Q. Tran et al.
BLOOD (2007)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism
Janine L. Coombes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
Maria-Grazia Roncarolo et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
Sarah E. Allan et al.
INTERNATIONAL IMMUNOLOGY (2007)
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
Vu H. Nguyen et al.
BLOOD (2007)
Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion
Petra Hoffmann et al.
BLOOD (2006)
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
Emmanuel Zorn et al.
BLOOD (2006)
Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance
Michiko Shimoda et al.
JOURNAL OF IMMUNOLOGY (2006)
MHC class II expression identifies functionally distinct human regulatory T cells
Clare Baecher-Allan et al.
JOURNAL OF IMMUNOLOGY (2006)
Antigen-specific regulatory T cells - Ex vivo expansion and therapeutic potential
EL Masteller et al.
SEMINARS IN IMMUNOLOGY (2006)
Protective conditioning for acute graft-versus-host disease
R Lowsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
A Beilhack et al.
BLOOD (2005)
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients
H Nishikawa et al.
BLOOD (2005)
Host-residual invariant NK T cells attenuate graft-versus-host immunity
K Haraguchi et al.
JOURNAL OF IMMUNOLOGY (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4-CD25- cells
MR Walker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
R Setoguchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD
J Ermann et al.
BLOOD (2005)
Cutting edge:: Contact-mediated suppression by CD4+-CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism
DC Gondek et al.
JOURNAL OF IMMUNOLOGY (2005)
Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
P Hoffmann et al.
BLOOD (2004)
L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
PA Taylor et al.
BLOOD (2004)
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes
QZ Tang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells
WJ Grossman et al.
BLOOD (2004)
IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells
PL Vieira et al.
JOURNAL OF IMMUNOLOGY (2004)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: The role of CD1-reactive natural killer T cells
FS Lan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response
SC Jones et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4(+)CD25(-) T cells
MR Walker et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion
M Higuchi et al.
JOURNAL OF IMMUNOLOGY (2002)
CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease
JL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β
K Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function
MK Levings et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells
MK Levings et al.
JOURNAL OF IMMUNOLOGY (2001)
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy
RS Wildin et al.
NATURE GENETICS (2001)
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
ME Brunkow et al.
NATURE GENETICS (2001)
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
CL Bennett et al.
NATURE GENETICS (2001)
NKT cells: facts, functions and fallacies
DI Godfrey et al.
IMMUNOLOGY TODAY (2000)
Share Paper
